Improved time to treatment failure with an intermittent oxaliplatin strategy: Results of CONcePT

Keyphrases

• Oxaliplatin 100%
• Time to Treatment Failure 100%
• Calcium Salts 50%
• Magnesium Salts 50%
• Hazard Ratio 20%
• Tumor Response 20%
• Neurotoxicity 20%
• Treatment Failure 20%
• Data Monitoring Committee 20%
• Significant Benefit 10%
• Integral Component 10%
• Dosing Schedule 10%
• Treatment Effect 10%
• Placebo 10%
• Time-to-treatment 10%
• Treatment Duration 10%
• Tumor Progression 10%
• Treatment Schedule 10%
• Prevention Trials 10%
• No Adverse Effect 10%
• Colorectal Cancer Prevention 10%
• Time to Tumor Progression 10%
• Study Termination 10%
• Bevacizumab 10%
• Response Evaluation Criteria in Solid Tumors (RECIST) 10%
• Oxaliplatin Neurotoxicity 10%
• Radiology Review 10%
• Double Randomization 10%

Medicine and Dentistry

• Time to Treatment 100%
• Oxaliplatin 100%
• Magnesium Salt 45%
• Calcium Salt 45%
• Neurotoxicity 27%
• Neoplasm 18%
• Hazard Ratio 18%
• Tumor Progression 18%
• Cancer Therapy 9%
• Infusion 9%
• Placebo 9%
• Adverse Event 9%
• Radiology 9%
• Colorectal Carcinoma 9%
• Response Evaluation Criteria in Solid Tumors 9%
• Bevacizumab 9%
• Treatment Duration 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Oxaliplatin 100%
• Calcium Salt 45%
• Magnesium Salt 45%
• Neurotoxicity 27%
• Neoplasm 18%
• Tumor Growth 18%
• Placebo 9%
• Solid Malignant Neoplasm 9%
• Adverse Event 9%
• Colorectal Carcinoma 9%
• Bevacizumab 9%